Chemical synthesis as a discovery platform in immunosuppression and determination of mode of action

Manuel Schupp, Iakovos Saridakis, Daniel Kaiser, Nuno Maulide (Korresp. Autor*in)

Veröffentlichungen: Beitrag in FachzeitschriftReviewPeer Reviewed

Abstract

Over the past century, the use of organ transplantation to replace malfunctioning tissue has leapt from an impossibility to being a routine procedure. This development has hinged on the use of immunosuppressive agents, which prevent rejection of the transplanted tissue. The most potent immunosuppressive drugs employed today are natural products and derivatives thereof, whose discovery, elucidation of mode of action, and introduction into clinical use have been enabled by chemical synthesis. However, more recently, research focusing on immunosuppressive natural products has not been able to identify novel scaffolds for clinical use. Here we discuss examples of immunosuppressive natural products in clinical use, explore how synthesis has contributed to our understanding of the mode of action as well as fundamental biology, and how synthetic chemistry could provide a means for future developments in this area.

OriginalspracheEnglisch
Seiten (von - bis)162-174
Seitenumfang13
FachzeitschriftNature Synthesis
Jahrgang3
Ausgabenummer2
Frühes Online-Datum4 Jan. 2024
DOIs
PublikationsstatusVeröffentlicht - Feb. 2024

ÖFOS 2012

  • 104015 Organische Chemie
  • 301207 Pharmazeutische Chemie
  • 301208 Pharmazeutische Technologie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Chemical synthesis as a discovery platform in immunosuppression and determination of mode of action“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitationsweisen